The NMDA receptor partial agonist d-cycloserine does not enhance motor learning
- PMID: 27436230
- PMCID: PMC5066480
- DOI: 10.1177/0269881116658988
The NMDA receptor partial agonist d-cycloserine does not enhance motor learning
Abstract
Rationale: There has recently been increasing interest in pharmacological manipulations that could potentially enhance exposure-based cognitive behaviour therapy for anxiety disorders. One such medication is the partial NMDA agonist d-cycloserine. It has been suggested that d-cycloserine enhances cognitive behaviour therapy by making learning faster. While animal studies have supported this view of the drug accelerating learning, evidence in human studies has been mixed. We therefore designed an experiment to measure the effects of d-cycloserine on human motor learning.
Methods: Fifty-four healthy human volunteers were randomly assigned to a single dose of 250mg d-cycloserine versus placebo in a double-blind design. They then performed a motor sequence learning task.
Results: D-cycloserine did not increase the speed of motor learning or the overall amount learnt. However, we noted that participants on d-cycloserine tended to respond more carefully (shifting towards slower, but more correct responses).
Conclusion: The results suggest that d-cycloserine does not exert beneficial effects on psychological treatments via mechanisms involved in motor learning. Further studies are needed to clarify the influence on other cognitive mechanisms.
Keywords: NMDA; d-cycloserine; motor learning.
© The Author(s) 2016.
Conflict of interest statement
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures

Similar articles
-
Human perceptual learning is delayed by the N-methyl-D-aspartate receptor partial agonist D-cycloserine.J Psychopharmacol. 2021 Mar;35(3):253-264. doi: 10.1177/0269881120986349. Epub 2021 Feb 11. J Psychopharmacol. 2021. PMID: 33570017 Free PMC article. Clinical Trial.
-
Combining d-cycloserine with motor training does not result in improved general motor learning in neurologically intact people or in people with stroke.J Neurophysiol. 2014 Jun 15;111(12):2516-24. doi: 10.1152/jn.00882.2013. Epub 2014 Mar 26. J Neurophysiol. 2014. PMID: 24671538 Free PMC article. Clinical Trial.
-
A role beyond learning for NMDA receptors in reward-based decision-making-a pharmacological study using d-cycloserine.Neuropsychopharmacology. 2014 Nov;39(12):2900-9. doi: 10.1038/npp.2014.144. Epub 2014 Jun 13. Neuropsychopharmacology. 2014. PMID: 24924800 Free PMC article. Clinical Trial.
-
NMDA receptors and fear extinction: implications for cognitive behavioral therapy.Dialogues Clin Neurosci. 2011;13(4):463-74. doi: 10.31887/DCNS.2011.13.4/mdavis. Dialogues Clin Neurosci. 2011. PMID: 22275851 Free PMC article. Review.
-
D-cycloserine as an augmentation strategy for cognitive behavioral therapy for anxiety disorders: an update.Curr Pharm Des. 2012;18(35):5659-62. doi: 10.2174/138161212803530916. Curr Pharm Des. 2012. PMID: 22632472 Review.
Cited by
-
Maintenance of antidepressant and antisuicidal effects by D-cycloserine among patients with treatment-resistant depression who responded to low-dose ketamine infusion: a double-blind randomized placebo-control study.Neuropsychopharmacology. 2019 Nov;44(12):2112-2118. doi: 10.1038/s41386-019-0480-y. Epub 2019 Aug 17. Neuropsychopharmacology. 2019. PMID: 31421635 Free PMC article. Clinical Trial.
-
NMDA receptor-related mechanisms of dopaminergic modulation of tDCS-induced neuroplasticity.Cereb Cortex. 2022 Nov 21;32(23):5478-5488. doi: 10.1093/cercor/bhac028. Cereb Cortex. 2022. PMID: 35165699 Free PMC article.
-
The effects of post-learning alcohol ingestion on human motor memory consolidation.Eur J Neurosci. 2022 Sep;56(5):4600-4618. doi: 10.1111/ejn.15772. Epub 2022 Jul 25. Eur J Neurosci. 2022. PMID: 35841189 Free PMC article.
-
Human perceptual learning is delayed by the N-methyl-D-aspartate receptor partial agonist D-cycloserine.J Psychopharmacol. 2021 Mar;35(3):253-264. doi: 10.1177/0269881120986349. Epub 2021 Feb 11. J Psychopharmacol. 2021. PMID: 33570017 Free PMC article. Clinical Trial.
-
Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research.Br J Pharmacol. 2017 Oct;174(19):3136-3160. doi: 10.1111/bph.13919. Epub 2017 Aug 11. Br J Pharmacol. 2017. PMID: 28626937 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources